New Delhi: The phase 2 human clinical trial of Oxford Covid-19 Vaccine , by Pune based Serum Institute of India (SII) is set to commence from Tuesday.
“We have got all approvals from the Central Drugs Standard Control Organisation (CDSCO). We are going to start the human clinical trial process at the BharatiVidyapeeth (Deemed to be University) Medical College and Hospital from August 25.We are sure that in line with the philosophy of our group, we are going to make available a world class COVID-19 vaccine for people of our country and make our country ‘AatmaNirbhar’,” said Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs, Serum Institute of India (SII).
Janet Elizabeth John@samacharline
